chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Paraesthesia, Periorbital swelling, Pharyngeal hypoaesthesia
Clinical narrative: Lt arm became numb & weak w/muscle tightness, legs & feet become numb and face/throat became numb; tingling and muscle tightness along with bilateral knee pain; muscle tightness/forearm muscle tightness; face/throat became numb along with a puffy eyelid; Lt arm became numb & weak w/muscle tightness; face/throat became numb along with a puffy eyelid; tingling and muscle tightness along with bilateral knee pain; This is a spontaneous report from a contactable nurse (patient). A 56-year-old non pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number: EL0142), via an unspecified route of administration, administered in left arm on 06Jan2021 (at the age of 56-year-old) as single dose for COVID-19 immunisation. Medical history included hypertension and high Cholesterol. The patient had no known allergies. The patient's concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive other vaccine in four weeks. Within 5 minutes of received the first vaccine on 06Jan2021, the patient had left arm became numb and weak with muscle tightness; then 1-2 hrs later legs and feet became numb with tingling and muscle tightness along with bilateral knee pain; then 2 hrs later the left side of face/throat became numb along with a puffy eyelid; this lasted 8 days then started resolving; then by the 12th day all symptoms stopped resolving and returned along with right arm numbness/paresthesia and forearm muscle tightness; the numbness and muscle tightening in arms and legs lasted another 2 days; patient still (at the time of report) had some left facial numbness along with paresthesia in both arms elbow to fingers and both legs knees to feet along with occasional knee pain. The patient went to the urgent care on day 2 post vaccine symptoms and day and day 12 post vaccine and was prescribed a muscle relaxant. The patient underwent lab tests and procedures which included nasal swab: negative on 01Feb2021. Therapeutic measures were taken as a result of events and treatment with muscle relaxant. The outcome of the events was resolving.  Follow-up attempts are completed. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Eyelid disorder, Hypoaesthesia, Muscle tightness, Muscular weakness
Clinical narrative: Lt arm became numb & weak w/muscle tightness, legs & feet become numb and face/throat became numb; tingling and muscle tightness along with bilateral knee pain; muscle tightness/forearm muscle tightness; face/throat became numb along with a puffy eyelid; Lt arm became numb & weak w/muscle tightness; face/throat became numb along with a puffy eyelid; tingling and muscle tightness along with bilateral knee pain; This is a spontaneous report from a contactable nurse (patient). A 56-year-old non pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number: EL0142), via an unspecified route of administration, administered in left arm on 06Jan2021 (at the age of 56-year-old) as single dose for COVID-19 immunisation. Medical history included hypertension and high Cholesterol. The patient had no known allergies. The patient's concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive other vaccine in four weeks. Within 5 minutes of received the first vaccine on 06Jan2021, the patient had left arm became numb and weak with muscle tightness; then 1-2 hrs later legs and feet became numb with tingling and muscle tightness along with bilateral knee pain; then 2 hrs later the left side of face/throat became numb along with a puffy eyelid; this lasted 8 days then started resolving; then by the 12th day all symptoms stopped resolving and returned along with right arm numbness/paresthesia and forearm muscle tightness; the numbness and muscle tightening in arms and legs lasted another 2 days; patient still (at the time of report) had some left facial numbness along with paresthesia in both arms elbow to fingers and both legs knees to feet along with occasional knee pain. The patient went to the urgent care on day 2 post vaccine symptoms and day and day 12 post vaccine and was prescribed a muscle relaxant. The patient underwent lab tests and procedures which included nasal swab: negative on 01Feb2021. Therapeutic measures were taken as a result of events and treatment with muscle relaxant. The outcome of the events was resolving.  Follow-up attempts are completed. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Oropharyngeal discomfort, Paraesthesia, SARS-CoV-2 antibody test
Clinical narrative: Lt arm became numb & weak w/muscle tightness, legs & feet become numb and face/throat became numb; tingling and muscle tightness along with bilateral knee pain; muscle tightness/forearm muscle tightness; face/throat became numb along with a puffy eyelid; Lt arm became numb & weak w/muscle tightness; face/throat became numb along with a puffy eyelid; tingling and muscle tightness along with bilateral knee pain; This is a spontaneous report from a contactable nurse (patient). A 56-year-old non pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number: EL0142), via an unspecified route of administration, administered in left arm on 06Jan2021 (at the age of 56-year-old) as single dose for COVID-19 immunisation. Medical history included hypertension and high Cholesterol. The patient had no known allergies. The patient's concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive other vaccine in four weeks. Within 5 minutes of received the first vaccine on 06Jan2021, the patient had left arm became numb and weak with muscle tightness; then 1-2 hrs later legs and feet became numb with tingling and muscle tightness along with bilateral knee pain; then 2 hrs later the left side of face/throat became numb along with a puffy eyelid; this lasted 8 days then started resolving; then by the 12th day all symptoms stopped resolving and returned along with right arm numbness/paresthesia and forearm muscle tightness; the numbness and muscle tightening in arms and legs lasted another 2 days; patient still (at the time of report) had some left facial numbness along with paresthesia in both arms elbow to fingers and both legs knees to feet along with occasional knee pain. The patient went to the urgent care on day 2 post vaccine symptoms and day and day 12 post vaccine and was prescribed a muscle relaxant. The patient underwent lab tests and procedures which included nasal swab: negative on 01Feb2021. Therapeutic measures were taken as a result of events and treatment with muscle relaxant. The outcome of the events was resolving.  Follow-up attempts are completed. No further information is expected.
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Joint swelling, Peripheral swelling, Thrombosis, Ultrasound scan
Clinical narrative: swollen right ankle and foot; swollen right ankle and foot; blood blockage; little sore in the arm; This is a spontaneous report from a contactable consumer (son). A 74-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: Unknown), via an unspecified route of administration on 20Jan2021 (at the age of 74-year-old) as 1st dose, single for COVID-19 immunisation. The patient's medical history included abnormal lymph node growth for the past few years. She has had biopsies several times to make sure it is not cancer. The most recent was within the past year or the year prior. Concomitant medications included clonazepam, half a pill taken for anxiety and unspecified drug for high blood pressure. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On an unknown date, the patient experienced swollen right ankle and foot and blood blockage vessels. The reporter stated that the patient had a little sore in the arm. Patient was worried to take the second one. Patient went to her primary doctor and ultrasound of the leg was ordered. They discovered a blood blockage of the vessels. The doctor put her on Eliquis 5mg twice a day immediately on 02Feb2021 and told her to see her haematologist. The patient underwent lab tests and procedures which included biopsy: unknown, blood test: unknown, ultrasound scan: unknown. The clinical outcome of all the events was unknown  Information on the lot/batch number has been requested.  The information about lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Angiopathy, Biopsy, Blood test, Joint swelling, Pain in extremity
Clinical narrative: swollen right ankle and foot; swollen right ankle and foot; blood blockage; little sore in the arm; This is a spontaneous report from a contactable consumer (son). A 74-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: Unknown), via an unspecified route of administration on 20Jan2021 (at the age of 74-year-old) as 1st dose, single for COVID-19 immunisation. The patient's medical history included abnormal lymph node growth for the past few years. She has had biopsies several times to make sure it is not cancer. The most recent was within the past year or the year prior. Concomitant medications included clonazepam, half a pill taken for anxiety and unspecified drug for high blood pressure. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On an unknown date, the patient experienced swollen right ankle and foot and blood blockage vessels. The reporter stated that the patient had a little sore in the arm. Patient was worried to take the second one. Patient went to her primary doctor and ultrasound of the leg was ordered. They discovered a blood blockage of the vessels. The doctor put her on Eliquis 5mg twice a day immediately on 02Feb2021 and told her to see her haematologist. The patient underwent lab tests and procedures which included biopsy: unknown, blood test: unknown, ultrasound scan: unknown. The clinical outcome of all the events was unknown  Information on the lot/batch number has been requested.  The information about lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Peripheral swelling, Ultrasound scan
Clinical narrative: swollen right ankle and foot; swollen right ankle and foot; blood blockage; little sore in the arm; This is a spontaneous report from a contactable consumer (son). A 74-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: Unknown), via an unspecified route of administration on 20Jan2021 (at the age of 74-year-old) as 1st dose, single for COVID-19 immunisation. The patient's medical history included abnormal lymph node growth for the past few years. She has had biopsies several times to make sure it is not cancer. The most recent was within the past year or the year prior. Concomitant medications included clonazepam, half a pill taken for anxiety and unspecified drug for high blood pressure. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On an unknown date, the patient experienced swollen right ankle and foot and blood blockage vessels. The reporter stated that the patient had a little sore in the arm. Patient was worried to take the second one. Patient went to her primary doctor and ultrasound of the leg was ordered. They discovered a blood blockage of the vessels. The doctor put her on Eliquis 5mg twice a day immediately on 02Feb2021 and told her to see her haematologist. The patient underwent lab tests and procedures which included biopsy: unknown, blood test: unknown, ultrasound scan: unknown. The clinical outcome of all the events was unknown  Information on the lot/batch number has been requested.  The information about lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Trigeminal neuralgia
Clinical narrative: Trigeminal Neuralgia; This is a spontaneous report from a contactable consumer(patient). A 70-Year-Old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number: EN5318), via an unspecified route of administration on 04Feb2021 at 14:00 into left arm as a single dose for COVID-19 immunization. Medical history included asthma from an unknown date and unknown if ongoing, hypertension from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient previously took ciprofloxacin and experienced drug hypersensitivity. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccine within 4 weeks. The patient received other medications in two weeks. On 08Feb2021 at 07:00 AM, 4 days after vaccination patient experienced symptoms of Trigeminal neuralgia. Patient was visited to Doctor or other healthcare professional office/clinic visit for the event. No treatment was given for the event. The outcome of the event was not recovered.  Follow-up (17Jun2021): Follow-up attempts completed. No further information expected.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Toothache
Clinical narrative: tooth pain; This is a spontaneous report from a contactable consumer (himself). A male patient of unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: unknown, Expiry date not reported) via unspecified route of administration on unspecified date as first dose, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. It was reported that he got the first Pfizer Covid vaccine on Monday. Patient took Tylenol after getting the first dose of the PFIZER-BIONTECH COVID-19 VACCINE to manage toothache. The next day, this had nothing to do with the shot, but he developed a tooth problem and developed pain. He took Tylenol and the next day he had the same thing and took a couple more Tylenol and today he took one Tylenol at 11am. He spoke with someone who told him he should not have taken the Tylenol because it would reduce the effectiveness of the vaccine. He was calling to find out if Tylenol has any impact on the vaccine. Caller was going at the end of February to get the second one and knows the second one tends to have more of a reaction and just wants to know this before then. The outcome of event was unknown.   Follow-up attempts have been completed and no further information is expected.
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Dyspnoea, Electrocardiogram, Rash
Clinical narrative: shortness of breath; Lightheaded; This is a spontaneous report from a contactable consumer (patient, self-reporting). A 70-years-old non pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number: not reported), via an unspecified route of administration in left arm on 26Feb2021 at 11:00 (age at vaccination: 70 years) as 1ST dose, single for COVID-19 immunisation. The patient was vaccinated in hospital. The patient did not receive any other medications in 4 weeks. The patient's medical history included drug hypersensitivity to penicillin. Concomitant medication(s) included atorvastatin (LIPITOR) and ciclosporin (RESTASIS). On 26Feb2021 at 12:00, the patient experienced shortness of breath and lightheaded. The patient received Zyrtec as treatment for the events. The adverse event resulted in doctor or other healthcare professional office/clinic visit. The patient did not have COVID prior vaccination not was tested for COVID post vaccination. The outcome of all the events was reported as recovering.  Information on the lot/batch number has been requested.  Follow-up (13May2021): Follow-up attempts completed. No further information expected.
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Dyspnoea
Clinical narrative: shortness of breath; Lightheaded; This is a spontaneous report from a contactable consumer (patient, self-reporting). A 70-years-old non pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number: not reported), via an unspecified route of administration in left arm on 26Feb2021 at 11:00 (age at vaccination: 70 years) as 1ST dose, single for COVID-19 immunisation. The patient was vaccinated in hospital. The patient did not receive any other medications in 4 weeks. The patient's medical history included drug hypersensitivity to penicillin. Concomitant medication(s) included atorvastatin (LIPITOR) and ciclosporin (RESTASIS). On 26Feb2021 at 12:00, the patient experienced shortness of breath and lightheaded. The patient received Zyrtec as treatment for the events. The adverse event resulted in doctor or other healthcare professional office/clinic visit. The patient did not have COVID prior vaccination not was tested for COVID post vaccination. The outcome of all the events was reported as recovering.  Information on the lot/batch number has been requested.  Follow-up (13May2021): Follow-up attempts completed. No further information expected.
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Asthenia, Blood test normal, Chills, Dizziness
Clinical narrative: Difficulty breathing at times; Tiredness; Chills; Injection site redness; Feeling unwell; Joint pain; Dizziness; Weakness; This is a spontaneous report received from a contactable consumer or other non-health care professional (Patient). A 73-years-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot/Batch number: EN6205), via an unspecified route of administration, administered in Arm Left on 01Mar2021 14:00 as 1st dose, single for covid-19 immunisation. Medical history included covid-19. If Covid prior vaccination: Yes. Patient not had Known allergies. Concomitant medications included propanolol hcl 60mg, omeprazole 20mg, acetylsalicylic acid (ASPIRIN 81) 81mg. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, did not patient been tested for COVID-19. On 02Mar2021 14:00, The patient experienced tiredness, chills, injection site redness, feeling unwell, joint pain, difficulty breathing at times, dizziness and weakness . Patient visited Emergency room/department or urgent care. Therapeutic measures were taken as EKG, Blood work, Urinalysis for events. The outcome of the events was reported as not recovered.
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Electrocardiogram normal, Fatigue, Injection site erythema, Malaise
Clinical narrative: Difficulty breathing at times; Tiredness; Chills; Injection site redness; Feeling unwell; Joint pain; Dizziness; Weakness; This is a spontaneous report received from a contactable consumer or other non-health care professional (Patient). A 73-years-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot/Batch number: EN6205), via an unspecified route of administration, administered in Arm Left on 01Mar2021 14:00 as 1st dose, single for covid-19 immunisation. Medical history included covid-19. If Covid prior vaccination: Yes. Patient not had Known allergies. Concomitant medications included propanolol hcl 60mg, omeprazole 20mg, acetylsalicylic acid (ASPIRIN 81) 81mg. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, did not patient been tested for COVID-19. On 02Mar2021 14:00, The patient experienced tiredness, chills, injection site redness, feeling unwell, joint pain, difficulty breathing at times, dizziness and weakness . Patient visited Emergency room/department or urgent care. Therapeutic measures were taken as EKG, Blood work, Urinalysis for events. The outcome of the events was reported as not recovered.
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Urine analysis
Clinical narrative: Difficulty breathing at times; Tiredness; Chills; Injection site redness; Feeling unwell; Joint pain; Dizziness; Weakness; This is a spontaneous report received from a contactable consumer or other non-health care professional (Patient). A 73-years-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot/Batch number: EN6205), via an unspecified route of administration, administered in Arm Left on 01Mar2021 14:00 as 1st dose, single for covid-19 immunisation. Medical history included covid-19. If Covid prior vaccination: Yes. Patient not had Known allergies. Concomitant medications included propanolol hcl 60mg, omeprazole 20mg, acetylsalicylic acid (ASPIRIN 81) 81mg. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, did not patient been tested for COVID-19. On 02Mar2021 14:00, The patient experienced tiredness, chills, injection site redness, feeling unwell, joint pain, difficulty breathing at times, dizziness and weakness . Patient visited Emergency room/department or urgent care. Therapeutic measures were taken as EKG, Blood work, Urinalysis for events. The outcome of the events was reported as not recovered.
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Asthenia, Chills, Dizziness, Dyspnoea
Clinical narrative: Difficulty breathing at times; Tiredness; Chills; Injection site redness; Feeling unwell; Joint pain; Dizziness; Weakness; This is a spontaneous report received from a contactable consumer or other non-health care professional (Patient). A 73-years-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot/Batch number: EN6205), via an unspecified route of administration, administered in Arm Left on 01Mar2021 14:00 as 1st dose, single for covid-19 immunisation. Medical history included covid-19. If Covid prior vaccination: Yes. Patient not had Known allergies. Concomitant medications included propanolol hcl 60mg, omeprazole 20mg, acetylsalicylic acid (ASPIRIN 81) 81mg. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, did not patient been tested for COVID-19. On 02Mar2021 14:00, The patient experienced tiredness, chills, injection site redness, feeling unwell, joint pain, difficulty breathing at times, dizziness and weakness . Patient visited Emergency room/department or urgent care. Therapeutic measures were taken as EKG, Blood work, Urinalysis for events. The outcome of the events was reported as not recovered.
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Malaise, Vaccination site erythema
Clinical narrative: Difficulty breathing at times; Tiredness; Chills; Injection site redness; Feeling unwell; Joint pain; Dizziness; Weakness; This is a spontaneous report received from a contactable consumer or other non-health care professional (Patient). A 73-years-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot/Batch number: EN6205), via an unspecified route of administration, administered in Arm Left on 01Mar2021 14:00 as 1st dose, single for covid-19 immunisation. Medical history included covid-19. If Covid prior vaccination: Yes. Patient not had Known allergies. Concomitant medications included propanolol hcl 60mg, omeprazole 20mg, acetylsalicylic acid (ASPIRIN 81) 81mg. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, did not patient been tested for COVID-19. On 02Mar2021 14:00, The patient experienced tiredness, chills, injection site redness, feeling unwell, joint pain, difficulty breathing at times, dizziness and weakness . Patient visited Emergency room/department or urgent care. Therapeutic measures were taken as EKG, Blood work, Urinalysis for events. The outcome of the events was reported as not recovered.
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Headache
Clinical narrative: pressure in head and ears; pressure in head and ears; severe headache; neck muscles are inflamed/tension inflammation; This is a spontaneous report from a contactable physician (patient) via Pfizer-sponsored program Pfizer. A 50-years-old female patient received first dose bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot number and Expiry date was not reported) as single dose for covid-19 immunisation.  The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced pressure in head and ears and severe headache. It was reported that the patient got the first dose of vaccine and within a minute after she got that She had experienced pressure in her head and her ears and that turned into a severe headache. She didn't take any medication for 30 minutes. After that she took some Motrin and Tylenol but it did not improve. She went to her Physician, who said her neck muscles are inflamed, it is called tension inflammation. Also gave her anti-inflammatory medications but headache was still there. She wanted to know if she needs to continue the 2nd dose of vaccine. Therapeutic measures were taken as a result of the reported events. Outcome of the events was unknown.  Follow-up attempts completed. No further information expected.
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Back pain, Head discomfort, Myalgia, Myositis, Neck pain
Clinical narrative: pressure in head and ears; pressure in head and ears; severe headache; neck muscles are inflamed/tension inflammation; This is a spontaneous report from a contactable physician (patient) via Pfizer-sponsored program Pfizer. A 50-years-old female patient received first dose bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot number and Expiry date was not reported) as single dose for covid-19 immunisation.  The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced pressure in head and ears and severe headache. It was reported that the patient got the first dose of vaccine and within a minute after she got that She had experienced pressure in her head and her ears and that turned into a severe headache. She didn't take any medication for 30 minutes. After that she took some Motrin and Tylenol but it did not improve. She went to her Physician, who said her neck muscles are inflamed, it is called tension inflammation. Also gave her anti-inflammatory medications but headache was still there. She wanted to know if she needs to continue the 2nd dose of vaccine. Therapeutic measures were taken as a result of the reported events. Outcome of the events was unknown.  Follow-up attempts completed. No further information expected.
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Tension headache
Clinical narrative: pressure in head and ears; pressure in head and ears; severe headache; neck muscles are inflamed/tension inflammation; This is a spontaneous report from a contactable physician (patient) via Pfizer-sponsored program Pfizer. A 50-years-old female patient received first dose bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot number and Expiry date was not reported) as single dose for covid-19 immunisation.  The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced pressure in head and ears and severe headache. It was reported that the patient got the first dose of vaccine and within a minute after she got that She had experienced pressure in her head and her ears and that turned into a severe headache. She didn't take any medication for 30 minutes. After that she took some Motrin and Tylenol but it did not improve. She went to her Physician, who said her neck muscles are inflamed, it is called tension inflammation. Also gave her anti-inflammatory medications but headache was still there. She wanted to know if she needs to continue the 2nd dose of vaccine. Therapeutic measures were taken as a result of the reported events. Outcome of the events was unknown.  Follow-up attempts completed. No further information expected.
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Ear discomfort, Head discomfort, Headache, Myositis
Clinical narrative: pressure in head and ears; pressure in head and ears; severe headache; neck muscles are inflamed/tension inflammation; This is a spontaneous report from a contactable physician (patient) via Pfizer-sponsored program Pfizer. A 50-years-old female patient received first dose bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot number and Expiry date was not reported) as single dose for covid-19 immunisation.  The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced pressure in head and ears and severe headache. It was reported that the patient got the first dose of vaccine and within a minute after she got that She had experienced pressure in her head and her ears and that turned into a severe headache. She didn't take any medication for 30 minutes. After that she took some Motrin and Tylenol but it did not improve. She went to her Physician, who said her neck muscles are inflamed, it is called tension inflammation. Also gave her anti-inflammatory medications but headache was still there. She wanted to know if she needs to continue the 2nd dose of vaccine. Therapeutic measures were taken as a result of the reported events. Outcome of the events was unknown.  Follow-up attempts completed. No further information expected.
Age: 96.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cardiac arrest, Death, Fatigue, Nausea
Clinical narrative: Facility reports pt noted to facility staff to have had an upset stomach earlier in the day on 2/5/21. Evening of 2/5/21, pt pressed her call light and became unresponsive.  She had a cardiac arrest and was brought to the Emergency Room by ambulance.  EMS was notified at 9:24 PM the last time she had been seen well was about 20 minutes prior.  They arrived at the hospital at 9:54 PM.  She had received several rounds of epinephrine and a dose of sodium bicarbonate.  She was in pulseless electrical activity with narrow complex rhythm. CPR was unsuccessful.  Resuscitative efforts were continued in the emergency department for about 20 more minutes.  This would have been a total downtime of 15 minutes if she arrested at at the time EMS was called.  She had no response to treatments.  Two bedside ultrasounds were performed to assess cardiac motion, minimal cardiac contraction was noted.  There was no pericardial effusion.  At no time did the patient regained pulses.  Resuscitative efforts were stopped and the patient was pronounced dead at 10:16 PM
Age: 96.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal discomfort, Anion gap increased, Blood bicarbonate decreased, Blood chloride normal, Blood creatinine normal
Clinical narrative: Facility reports pt noted to facility staff to have had an upset stomach earlier in the day on 2/5/21. Evening of 2/5/21, pt pressed her call light and became unresponsive.  She had a cardiac arrest and was brought to the Emergency Room by ambulance.  EMS was notified at 9:24 PM the last time she had been seen well was about 20 minutes prior.  They arrived at the hospital at 9:54 PM.  She had received several rounds of epinephrine and a dose of sodium bicarbonate.  She was in pulseless electrical activity with narrow complex rhythm. CPR was unsuccessful.  Resuscitative efforts were continued in the emergency department for about 20 more minutes.  This would have been a total downtime of 15 minutes if she arrested at at the time EMS was called.  She had no response to treatments.  Two bedside ultrasounds were performed to assess cardiac motion, minimal cardiac contraction was noted.  There was no pericardial effusion.  At no time did the patient regained pulses.  Resuscitative efforts were stopped and the patient was pronounced dead at 10:16 PM
Age: 96.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood glucose increased, Blood lactic acid decreased, Blood potassium normal, Blood sodium normal, Blood urea increased
Clinical narrative: Facility reports pt noted to facility staff to have had an upset stomach earlier in the day on 2/5/21. Evening of 2/5/21, pt pressed her call light and became unresponsive.  She had a cardiac arrest and was brought to the Emergency Room by ambulance.  EMS was notified at 9:24 PM the last time she had been seen well was about 20 minutes prior.  They arrived at the hospital at 9:54 PM.  She had received several rounds of epinephrine and a dose of sodium bicarbonate.  She was in pulseless electrical activity with narrow complex rhythm. CPR was unsuccessful.  Resuscitative efforts were continued in the emergency department for about 20 more minutes.  This would have been a total downtime of 15 minutes if she arrested at at the time EMS was called.  She had no response to treatments.  Two bedside ultrasounds were performed to assess cardiac motion, minimal cardiac contraction was noted.  There was no pericardial effusion.  At no time did the patient regained pulses.  Resuscitative efforts were stopped and the patient was pronounced dead at 10:16 PM
Age: 96.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Calcium ionised normal, Carbon dioxide, Cardiac arrest, Death, Echocardiogram
Clinical narrative: Facility reports pt noted to facility staff to have had an upset stomach earlier in the day on 2/5/21. Evening of 2/5/21, pt pressed her call light and became unresponsive.  She had a cardiac arrest and was brought to the Emergency Room by ambulance.  EMS was notified at 9:24 PM the last time she had been seen well was about 20 minutes prior.  They arrived at the hospital at 9:54 PM.  She had received several rounds of epinephrine and a dose of sodium bicarbonate.  She was in pulseless electrical activity with narrow complex rhythm. CPR was unsuccessful.  Resuscitative efforts were continued in the emergency department for about 20 more minutes.  This would have been a total downtime of 15 minutes if she arrested at at the time EMS was called.  She had no response to treatments.  Two bedside ultrasounds were performed to assess cardiac motion, minimal cardiac contraction was noted.  There was no pericardial effusion.  At no time did the patient regained pulses.  Resuscitative efforts were stopped and the patient was pronounced dead at 10:16 PM
Age: 96.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Glomerular filtration rate decreased, Haematocrit decreased, Laboratory test abnormal, Oxygen saturation decreased, PCO2 increased
Clinical narrative: Facility reports pt noted to facility staff to have had an upset stomach earlier in the day on 2/5/21. Evening of 2/5/21, pt pressed her call light and became unresponsive.  She had a cardiac arrest and was brought to the Emergency Room by ambulance.  EMS was notified at 9:24 PM the last time she had been seen well was about 20 minutes prior.  They arrived at the hospital at 9:54 PM.  She had received several rounds of epinephrine and a dose of sodium bicarbonate.  She was in pulseless electrical activity with narrow complex rhythm. CPR was unsuccessful.  Resuscitative efforts were continued in the emergency department for about 20 more minutes.  This would have been a total downtime of 15 minutes if she arrested at at the time EMS was called.  She had no response to treatments.  Two bedside ultrasounds were performed to assess cardiac motion, minimal cardiac contraction was noted.  There was no pericardial effusion.  At no time did the patient regained pulses.  Resuscitative efforts were stopped and the patient was pronounced dead at 10:16 PM
Age: 96.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pulseless electrical activity, Resuscitation, Unresponsive to stimuli, pH body fluid
Clinical narrative: Facility reports pt noted to facility staff to have had an upset stomach earlier in the day on 2/5/21. Evening of 2/5/21, pt pressed her call light and became unresponsive.  She had a cardiac arrest and was brought to the Emergency Room by ambulance.  EMS was notified at 9:24 PM the last time she had been seen well was about 20 minutes prior.  They arrived at the hospital at 9:54 PM.  She had received several rounds of epinephrine and a dose of sodium bicarbonate.  She was in pulseless electrical activity with narrow complex rhythm. CPR was unsuccessful.  Resuscitative efforts were continued in the emergency department for about 20 more minutes.  This would have been a total downtime of 15 minutes if she arrested at at the time EMS was called.  She had no response to treatments.  Two bedside ultrasounds were performed to assess cardiac motion, minimal cardiac contraction was noted.  There was no pericardial effusion.  At no time did the patient regained pulses.  Resuscitative efforts were stopped and the patient was pronounced dead at 10:16 PM
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest X-ray normal, Electrocardiogram normal, Herpes zoster
Clinical narrative: shingles on chest back and right ear; feverish; body aches; fatigue; This is a spontaneous report from a contactable other healthcare professional. A 41-Year-old non pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: EN6201), via unspecified route of administration in left arm on 15Feb2021 at 04:45 pm (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient has not had symptoms associated with COVID-19. Patient had not tested positive for COVID-19 since having the vaccine. No known allergies to medications, food, or other products. On 16Feb2021, the day after vaccine, the patient experienced feverish, body aches and fatigue. On 04Mar2021, two weeks after the shot the patient ended up with shingles on chest back and in right ear. Treatment (unspecified) for shingles was ongoing and one ER visit for doctor. Therapeutic measures were taken for the event shingles. The clinical outcome of the events feverish, body aches, fatigue and shingles were not recovered.   No follow-up attempts are possible. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Herpes zoster, Pain, Pyrexia
Clinical narrative: shingles on chest back and right ear; feverish; body aches; fatigue; This is a spontaneous report from a contactable other healthcare professional. A 41-Year-old non pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: EN6201), via unspecified route of administration in left arm on 15Feb2021 at 04:45 pm (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient has not had symptoms associated with COVID-19. Patient had not tested positive for COVID-19 since having the vaccine. No known allergies to medications, food, or other products. On 16Feb2021, the day after vaccine, the patient experienced feverish, body aches and fatigue. On 04Mar2021, two weeks after the shot the patient ended up with shingles on chest back and in right ear. Treatment (unspecified) for shingles was ongoing and one ER visit for doctor. Therapeutic measures were taken for the event shingles. The clinical outcome of the events feverish, body aches, fatigue and shingles were not recovered.   No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood pressure measurement, Body temperature, Chills, Dizziness, Feeling abnormal
Clinical narrative: she developed fever and dizziness and they are still going on; she developed fever and dizziness and they are still going on; This is a spontaneous report from a contactable consumer (patient) via Medical Information Team. A female patient of an unspecified age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) via an unspecified route of administration on 04Feb2021 as single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously took BNT162B2 for Covid-19 immunization. Caller got her second dose of the Covid vaccine on Thursday 04Feb and since then she developed fever and dizziness and they were still going on. She wanted to know how long they will last. Outcome of the events was not recovered.  Follow-up attempts are completed. No further information is expected.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypotension, Pyrexia
Clinical narrative: she developed fever and dizziness and they are still going on; she developed fever and dizziness and they are still going on; This is a spontaneous report from a contactable consumer (patient) via Medical Information Team. A female patient of an unspecified age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) via an unspecified route of administration on 04Feb2021 as single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously took BNT162B2 for Covid-19 immunization. Caller got her second dose of the Covid vaccine on Thursday 04Feb and since then she developed fever and dizziness and they were still going on. She wanted to know how long they will last. Outcome of the events was not recovered.  Follow-up attempts are completed. No further information is expected.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Pyrexia
Clinical narrative: she developed fever and dizziness and they are still going on; she developed fever and dizziness and they are still going on; This is a spontaneous report from a contactable consumer (patient) via Medical Information Team. A female patient of an unspecified age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) via an unspecified route of administration on 04Feb2021 as single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously took BNT162B2 for Covid-19 immunization. Caller got her second dose of the Covid vaccine on Thursday 04Feb and since then she developed fever and dizziness and they were still going on. She wanted to know how long they will last. Outcome of the events was not recovered.  Follow-up attempts are completed. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Burning sensation, Dysuria, Pollakiuria, Urinary tract infection, Urine analysis
Clinical narrative: urinary tract infections; This is a spontaneous report from a contactable consumer (patient). A 40-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: En6206) via an unspecified route of administration into the left arm on 08Mar2021 03:30 PM (at the age of 40-year-old) as 1st dose, single for COVID-19 immunisation. The patient medical history included known allergies to tetracycline. Concomitant medications were not reported. No other vaccine in four weeks nor any other medications in two weeks. No covid prior vaccination nor covid tested post vaccination. The patient reported that she rarely gets UTI (urinary tract infections), and within 6 days of the first vaccine shot, on 14Mar2021, at around 02:30 PM, she tested positive for a UTI. Not sure if it was linked or not but wanted to report it just in case. This resulted in doctor or other healthcare professional office/clinic visit and received treatment with macrobid antibiotic. Outcome of the event was not resolved.  No follow-up attempts are possible. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Urinary tract infection
Clinical narrative: urinary tract infections; This is a spontaneous report from a contactable consumer (patient). A 40-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: En6206) via an unspecified route of administration into the left arm on 08Mar2021 03:30 PM (at the age of 40-year-old) as 1st dose, single for COVID-19 immunisation. The patient medical history included known allergies to tetracycline. Concomitant medications were not reported. No other vaccine in four weeks nor any other medications in two weeks. No covid prior vaccination nor covid tested post vaccination. The patient reported that she rarely gets UTI (urinary tract infections), and within 6 days of the first vaccine shot, on 14Mar2021, at around 02:30 PM, she tested positive for a UTI. Not sure if it was linked or not but wanted to report it just in case. This resulted in doctor or other healthcare professional office/clinic visit and received treatment with macrobid antibiotic. Outcome of the event was not resolved.  No follow-up attempts are possible. No further information is expected.
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arthralgia, Myalgia
Clinical narrative: I am suffering from extreme pain in all of my joints; I am suffering from extreme pain in muscles also; I am suffering from severe exhaustion; I am suffering from headaches; I am suffering from nausea; This is a spontaneous report received from a contactable consumer, the patient. A 64-years-old male patient received his unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN] via an unspecified route of administration on an unspecified date, at the age of 64 years as a single dose, for COVID-19 immunisation. Medical history included chronic obstructive pulmonary disease, hypertension and gastroesophageal reflux disease. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. Concomitant medications included gabapentin (MANUFACTURER UNKNOWN), valsartan (MANUFACTURER UNKNOWN), hydrocortisone (MANUFACTURER UNKNOWN) and oxycodone (MANUFACTURER UNKNOWN). The patient suffered from extreme pain in all of my joints (joint pain) and muscles (muscle pain). The patient also suffered from severe exhaustion (exhaustion), headaches and nausea on 12Mar2021 at 12:00. The patient cannot do any day to day activities. The patient did not receive any treatment for events. The clinical outcome of events joint pain, muscle pain, exhaustion, headache and nausea were not recovered at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.